CTRI/2019/04/018362尚未招募未知
An open label crossover study to estimate Glycemic index of Murchit Atta as compare to Regular Atta in a patients with Type 2 Diabetes mellitus
Madhavbaug Multidisciplinary Cardiac Care Clinics and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients of either sex in the age group between 18 to 50 years (Both Inclusive)
- •2. Willing to provide written informed consent
- •3. Patients diagnosed to be suffering from Type 2 diabetes mellitus taking oral hypoglycemic drugs and with blood sugar stabilized within normal range(Fasting sugar level < 110 mg/dl and Postprandial sugar level < 140 mg/dl )
排除标准
- •1.Patients of either sex having age below 18 and above 50
- •2. Not willing to provide written inform consent
- •3. Patients diagnosed as Type 1 diabetes mellitus
- •4. Patients with past 30 days history
- •A) Any major illness that required hospitalization
- •B) acute exacerbation of any ongoing chronic medical illness e.g. Congestive cardiac failure Hepatitis Hypotensive episodes HIV etc Medications requiring change of doses for treatment of the chronic illness
- •5. Patients suffering from severe cardiac renal liver or any other organ impairment.
- •6. History of seizures epilepsy or any neurological disorders
- •7. Recent history of dehydration from diarrhoea vomiting or any other reason within a period of 24 hours prior to enrolment in the study
- •8. Patient with any history of food allergy or any ingredient of investigational Murchit atta
- •9. Pregnant or lactating females
研究者
相似试验
暂停
不适用
Estimate Glycemic index of Murchit Atta as compare to Regular AttaCTRI/2019/05/019386Madhavbaug Multidisciplinary Cardiac Care Clinics and Hospital
已完成
不适用
Open-label cross-over study to evaluate the amount of residual inhaled corticosteroid (hydrofluoroalkane-134a beclomethasone dipropionate (HFA-BDP) and fluticasone propionate dry powder inhaler (FP-DPI)) in the mouths of elderly asthmatic patients after each inhalatioAsthmaJPRN-UMIN000001323JA Gifu Kouseiren Tohno-Kousei Hospital22
已完成
不适用
An open label, crossover study to investigate the safety and tolerability of Sifrol® (pramipexole) (Boehringer Ingelheim) prolonged release tablets in order to establish the maximum tolerable dose and to assess bioequivalence of Pramipexole prolonged release tablets (Synthon B.V.) compared to Sifrol® prolonged release tablets (Boehringer Ingelheim) in healthy subjects in steady-state conditions10042258parkinson's diseaseNL-OMON36833Synthon B.V52
已完成
不适用
A study for measurement of Glycemic Index (GI) of two kinds of foods in adult males and femalesJPRN-UMIN000037071TTC Co., Ltd.12
招募中
Unknown
A single-center open-label crossover study of the clinical utility and safety of the BV-UFC system of the DCS-200Si dialysis monitorPatients undergoing hemodialysishemodialysisD006435JPRN-jRCT1062230034Hamada Shintaro20
